Retatrutide Weight Loss Drug Updates and Future Prospects | Retatrutide News

Philstar Life reports on updates for Retatrutide, a GLP-1 agonist in Eli Lilly's pipeline, through 2026. The drug is significant for weight loss and met...
Market News · October 19, 2026